Assessment of disease activity and treatment outcomes in rheumatoid arthritis.

Journal of managed care pharmacy : JMCP

Volumn 17, Issue 9 Suppl B, 2011, Pages

  Farheen, Kiran ^a   Agarwal, Sandeep K ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUTOANTIBODY; BIOLOGICAL MARKER; RHEUMATOID FACTOR;

BLOOD; DISEASE COURSE; HOSPITALIZATION; HUMAN; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84858274549     PISSN: None     EISSN: 1944706X     Source Type: Journal    
DOI: 10.18553/jmcp.2011.17.s9-b.s09     Document Type: Review

References (0)